Scientific Program | Pharmacovigilance Conference

Glenmark Pharma receives USFDA approval for generic antibiotic drug

2023-03-14 - 2023-03

Glenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator to market a generic antibiotic drug. The company has received final approval from the US Food & Drug Administration (USFDA) for Clindamycin Hydrochloride Capsules, a generic version of Pfizer's Cleocin capsules, Glenmark Pharma said in a statement. Glenmark's Clindamycin Hydrochloride Capsules in strengths of 75 mg, 150 mg, and 300 mg, will be distributed in the US by Glenmark Pharmaceuticals Inc, it added.

Cough syrup deaths: DCGI directs drug manufacturers not to use propylene glycol supplied by Delhi firm

2023-03-10 - 2023-03

India's drug regulator has directed drug manufacturers not to use propylene glycol supplied by a Delhi-based company which provided the ingredient to Marion Biotech, whose cough syrups were alleged to have led to the deaths of children in Uzbekistan. Maya Chemtech India Pvt. Ltd. supplied propylene glycol used in Marion Biotech's cough syrups that were found to be "not of standard quality", according to the regulator.

Abstracts enquiry

Registration enquiry

Contact Enquiry

Phone

WhatsApp

Useful Links

News

Glenmark Pharma receives USFDA approval for generic antibiotic drug

Cough syrup deaths: DCGI directs drug manufacturers not to use propylene glycol supplied by Delhi firm

Newsletter

Agenda

Pharmacovigilance Drug Safety

Glenmark Pharma receives USFDA approval for generic antibiotic drug

Cough syrup deaths: DCGI directs drug manufacturers not to use propylene glycol supplied by Delhi firm